These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3742030)

  • 1. [Reinforcing, but no analgesic, effect of opioid stimulation of the ventral tegmental area].
    Zvartau EE; Patkina NA; Morozova AS
    Biull Eksp Biol Med; 1986 Aug; 102(8):172-4. PubMed ID: 3742030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The receptor organization of the reinforcing and analgetic opiate systems in the rat].
    Patkina NA; Morozova AS; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(1):99-102. PubMed ID: 2544066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary-reinforcing effects of opiate agonists in the mouse].
    Zvartau EE; Kovalenko VS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(6):1069-76. PubMed ID: 3031897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing effects of morphine microinjection into the ventral tegmental area.
    Phillips AG; LePiane FG
    Pharmacol Biochem Behav; 1980 Jun; 12(6):965-8. PubMed ID: 7403209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat.
    Moaddab M; Haghparast A; Hassanpour-Ezatti M
    Behav Brain Res; 2009 Mar; 198(2):466-71. PubMed ID: 19073220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and morphine produce equivalent increases in extracellular single unit activity of dopamine neurons in the ventral tegmental area in vivo.
    Grant SJ; Sonti G
    Synapse; 1994 Mar; 16(3):181-7. PubMed ID: 8197580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of group-A10 dopamine neurons of the ventral tegmental area in analgesia evoked by electrocutaneous pain stimulation and morphine].
    Bragin EO; Batueva NN; Vasilenko GF
    Patol Fiziol Eksp Ter; 1990; (3):11-3. PubMed ID: 2399031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats.
    Bozarth MA
    Brain Res; 1987 Jun; 414(1):77-84. PubMed ID: 3620924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
    Noel MB; Gratton A
    Synapse; 1995 Oct; 21(2):110-22. PubMed ID: 8584972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways].
    Churiukanov VV
    Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.
    Bals-Kubik R; Ableitner A; Herz A; Shippenberg TS
    J Pharmacol Exp Ther; 1993 Jan; 264(1):489-95. PubMed ID: 8093731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats.
    Bodnar RJ; Lamonte N; Israel Y; Kandov Y; Ackerman TF; Khaimova E
    Peptides; 2005 Apr; 26(4):621-9. PubMed ID: 15752577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
    Comer SD; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):866-74. PubMed ID: 8246161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
    Popik P; Danysz W
    J Pharmacol Exp Ther; 1997 Feb; 280(2):854-65. PubMed ID: 9023300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study of the reinforcing and analgesic properties of cocaine].
    Kuz'min AV; Zvartau EE
    Eksp Klin Farmakol; 1993; 56(1):16-8. PubMed ID: 8391889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of opioid dependence and interaction between opioid receptors.
    Suzuki T; Kishimoto Y; Ozaki S; Narita M
    Eur J Pain; 2001; 5 Suppl A():63-5. PubMed ID: 11798220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mr 2033 CL--a novel non-morphine-like opioid analgesic.
    Stockhaus K; Ensinger HA; Gaida W; Jennewein HM; Merz H
    NIDA Res Monogr; 1983 Apr; 43():144-9. PubMed ID: 6135993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.